TuHURA Biosciences (HURA) Change in Accured Expenses (2012 - 2026)

TuHURA Biosciences' Change in Accured Expenses history runs 15 years deep, the most recent figure standing at $452006.0 for Q1 2026.

• On a quarterly basis, Change in Accured Expenses rose 1.45% year-over-year to $452006.0 in Q1 2026; TTM through Mar 2026 was -$3.8 million, a 1605.86% decrease from a year earlier, with the FY2025 full-year figure at -$3.8 million, down 203.19% from the prior year.
• Change in Accured Expenses rose to $452006.0 in Q1 2026 per HURA's latest filing, from $150447.0 in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $1.9 million in Q2 2025 and bottomed at -$6.2 million in Q3 2025.
• The 5-year median for Change in Accured Expenses is -$113000.0 (2022), against an average of -$473455.1.
• Across the five-year window, Change in Accured Expenses plunged 1802.47% in 2024 and jumped 605.99% in 2025, its largest moves.
• Year by year, Change in Accured Expenses stood at -$749000.0 in 2022, then slumped by 41.79% to -$1.1 million in 2023, then surged by 216.98% to $1.2 million in 2024, then plunged by 87.89% to $150447.0 in 2025, then jumped by 200.44% to $452006.0 in 2026.
• Per Business Quant, the three latest HURA Change in Accured Expenses figures stand at $452006.0 (Q1 2026), $150447.0 (Q4 2025), and -$6.2 million (Q3 2025).